Profile of:

Murat Torgutalp


Full name: Murat Torgutalp

Current country: Germany

Membership level: Full

Type of membership: Member

Number of publications: 20

Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial (2024)
https://pubmed.ncbi.nlm.nih.gov/38228361/

Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints (2023)
https://pubmed.ncbi.nlm.nih.gov/37093751/

Keep an Eye on the Back: Spondyloarthritis in Patients With Acute Anterior Uveitis (2023)
https://pubmed.ncbi.nlm.nih.gov/35905288/

Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37419620/

Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn’s disease: Clinical and MRI results from a prospective inception cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35227921/

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/35368376/

Treatment with Tumour Necrosis Factor Inhibitors is Associated with a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients with Axial Spondyloarthritis: 10-year Results from the German Spondyloarthritis Inception Cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35437900/

The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35451472/

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35697486/

Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/36003590/

Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/36323487/

Detection of radiographic sacroiliitis with an artificial neural network in patients with suspicion of axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34363456/

Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance (2021)
https://pubmed.ncbi.nlm.nih.gov/33832519/

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33796155/

Diagnosing axial spondyloarthritis: estimation of the disease probability in patients with a priori different likelihoods of the diagnosis (2021)
https://pubmed.ncbi.nlm.nih.gov/33693503/

Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial (2021)
https://pubmed.ncbi.nlm.nih.gov/34785545/

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) (2021)
https://pubmed.ncbi.nlm.nih.gov/34987619/

Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa (2020)
https://pubmed.ncbi.nlm.nih.gov/32911279/

IL-17 inhibition in axial spondyloarthritis: current and future perspectives (2019)
https://pubmed.ncbi.nlm.nih.gov/30957574/

Emerging treatment options for spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/31171316/